SCHOTT Developing Syringe Production in United States

SCHOTT’s Pharmaceutical Packaging business announced an expansion of both its product line and production capacity in the United States today. The company will add the full line of SCHOTT ready-to-fill syringe products to its portfolio of vials and cartridges manufactured at its existing Pharmaceutical Packaging facility in Lebanon, Penn.

The company expects to add 125 new jobs to its Lebanon facility and will begin hiring this year. The expansion into the syringe market represents a $46 million investment in the facility by SCHOTT.

The expansion of both the product line and U.S. production capacity is designed to meet the accelerating demand for syringes in the North American market. Market analysis shows global demand for prefilled syringes will grow at a rate of 8 - 10 percent a year for the next several years. Ready-to-fill syringes answer the growing market demand for speed and ease of use, while minimizing dosage errors.

“Demand for syringes in the United States has grown steadily in recent years and will continue with the increased incidence and detection of chronic diseases,” said Gary Waller, Director North American Sales & Marketing for SCHOTT Pharmaceutical Packaging. “SCHOTT is well positioned to leverage its high-quality global production capabilities for the U.S. market.”

All SCHOTT products and production processes will conform to the U.S. Food and Drug Administration’s current good manufacturing practice standards. The three-shift production schedule incorporates the most advanced techniques, including dimensional camera inspection and clean room final packaging.